featured
Teclistamab for Relapsed/Refractory Multiple Myeloma in the Real World
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Blood Cancer J 2024 Mar 05;14(1)35, M Mohan, J Monge, N Shah, D Luan, M Forsberg, V Bhatlapenumarthi, M Balev, A Patwari, H Cheruvalath, D Bhutani, S Thanendrarajan, B Dhakal, M Zangari, S Al-Hadidi, D Cooper, S Lentzsch, F van Rhee, A D'Souza, A Szabo, C Schinke, R ChakrabortyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.